Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ESK-001 for plaque psoriasis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ESK-001

Snippet

Sponsor: Alumis Inc | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2024-07-23